Operator
Good morning, and welcome to the ImmunoGen s First Quarter of 2021 Financial and Operating Results Conference Call. Today s conference is being recorded. At this time, I d like to turn the call over to Courtney O Konek, Senior Director of Corporate Communications and Investor Relations. Ma am, please go ahead.
Courtney O Konek
Senior Director of Corporate Communications and Investor Relations
Good morning, and thank you for joining today s call. Earlier today, we issued a press release that includes a summary of our recent progress in first quarter 2021 financial results. This press release and a recording of this call can be found under the Investors & Media section of our website at immunogen.com.
Operator
Good morning and welcome to ImmunoGen s Fourth Quarter and Full-Year 2020 Financial and Operating Results Conference Call. Today s conference is being recorded.
At this time, I would like to turn the call over to Courtney O Konek, Senior Director of Corporate Communications and Investor Relations. Please go ahead.
Courtney O Konek
Senior Director of Corporate Communications and Investor Relations
Good morning, and thank you for joining today s call. Earlier today, we issued a press release that includes a summary of our recent progress and fourth quarter and full-year 2020 financial results. This press release and a recording of this call can be found under the Investor and Media section of our website at immunogen.com.